Literature DB >> 23613085

Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks?

S J Cleland1, B M Fisher, H M Colhoun, N Sattar, J R Petrie.   

Abstract

In this review, we explore the concept of 'double diabetes', a combination of type 1 diabetes with features of insulin resistance and type 2 diabetes. After considering whether double diabetes is a useful concept, we discuss potential mechanisms of increased insulin resistance in type 1 diabetes before examining the extent to which double diabetes might increase the risk of cardiovascular disease (CVD). We then go on to consider the proposal that weight gain from intensive insulin regimens may be associated with increased CV risk factors in some patients with type 1 diabetes, and explore the complex relationships between weight gain, insulin resistance, glycaemic control and CV outcome. Important comparisons and contrasts between type 1 diabetes and type 2 diabetes are highlighted in terms of hepatic fat, fat partitioning and lipid profile, and how these may differ between type 1 diabetic patients with and without double diabetes. In so doing, we hope this work will stimulate much-needed research in this area and an improvement in clinical practice.

Entities:  

Mesh:

Year:  2013        PMID: 23613085      PMCID: PMC3671104          DOI: 10.1007/s00125-013-2904-2

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  58 in total

Review 1.  Causes and metabolic consequences of Fatty liver.

Authors:  Norbert Stefan; Konstantinos Kantartzis; Hans-Ulrich Häring
Journal:  Endocr Rev       Date:  2008-08-21       Impact factor: 19.871

2.  The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population.

Authors:  J R Erbey; L H Kuller; D J Becker; T J Orchard
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

3.  Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites, and hormones in type I diabetes mellitus.

Authors:  J L Selam; M Kashyap; K G Alberti; J Lozano; M Hanna; D Turner; N Jeandidier; E Chan; M A Charles
Journal:  Metabolism       Date:  1989-09       Impact factor: 8.694

4.  Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects.

Authors:  R W James; D Pometta
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

5.  Normal VLDL metabolism despite altered lipoprotein composition in type 1 diabetes mellitus.

Authors:  E R Christ; P V Carroll; E Albany; A M Umpleby; P J Lumb; A S Wierzbicki; H L Simpson; P H Sönksen; D L Russell-Ones
Journal:  Clin Endocrinol (Oxf)       Date:  2001-12       Impact factor: 3.478

6.  Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes.

Authors:  Shalamar D Sibley; Jerry P Palmer; Irl B Hirsch; John D Brunzell
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

7.  Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin dependent diabetes compared with puberty matched controls.

Authors:  A M Taylor; D B Dunger; D B Grant; M A Preece
Journal:  Diabetes Res       Date:  1988-12

Review 8.  Diabetic dyslipidaemia: from basic research to clinical practice.

Authors:  M-R Taskinen
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

9.  Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis.

Authors:  Jan Frystyk; Robert A Ritzel; J Maubach; Martin Büsing; Rainer Lück; Jürgen Klempnauer; Wolff Schmiegel; Michael A Nauck
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958

10.  Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.

Authors:  G Ruotolo; M Parlavecchia; M R Taskinen; G Galimberti; A Zoppo; N A Le; F Ragogna; P Micossi; G Pozza
Journal:  Diabetes Care       Date:  1994-01       Impact factor: 19.112

View more
  63 in total

Review 1.  Early diabetic nephropathy in type 1 diabetes: new insights.

Authors:  Petter Bjornstad; David Cherney; David M Maahs
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-08       Impact factor: 3.243

Review 2.  Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now?

Authors:  Jencia Wong; Maria Constantino; Dennis K Yue
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

3.  Gastric Bypass in an Adolescent with Obesity, Insulin Resistance, and Type 1 Diabetes.

Authors:  Margaret A Stefater; Brynn E Marks
Journal:  Obes Surg       Date:  2021-01-16       Impact factor: 4.129

Review 4.  Insulin sensitivity and complications in type 1 diabetes: New insights.

Authors:  Petter Bjornstad; Janet K Snell-Bergeon; Kristen J Nadeau; David M Maahs
Journal:  World J Diabetes       Date:  2015-02-15

5.  Exercise effects on postprandial glucose metabolism in type 1 diabetes: a triple-tracer approach.

Authors:  Ashwini Mallad; Ling Hinshaw; Michele Schiavon; Chiara Dalla Man; Vikash Dadlani; Rita Basu; Ravi Lingineni; Claudio Cobelli; Matthew L Johnson; Rickey Carter; Yogish C Kudva; Ananda Basu
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-21       Impact factor: 4.310

6.  Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes.

Authors:  Clare B Kelly; Michelle B Hookham; Jeremy Y Yu; Samuel M Lockhart; Mei Du; Alicia J Jenkins; Alison Nankervis; Kristian F Hanssen; Tore Henriksen; Satish K Garg; Samar M Hammad; James A Scardo; Christopher E Aston; Christopher C Patterson; Timothy J Lyons
Journal:  Diabetologia       Date:  2017-09-05       Impact factor: 10.122

7.  Diabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.

Authors:  Petter Bjornstad; David M Maahs
Journal:  Curr Pediatr Rep       Date:  2015-04-04

8.  Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes.

Authors:  Leah M Lipsky; Benjamin Gee; Aiyi Liu; Tonja R Nansel
Journal:  Diabetes Res Clin Pract       Date:  2016-08-06       Impact factor: 5.602

Review 9.  Why do some patients with type 1 diabetes live so long?

Authors:  Larry A Distiller
Journal:  World J Diabetes       Date:  2014-06-15

10.  Serum uric acid and insulin sensitivity in adolescents and adults with and without type 1 diabetes.

Authors:  Petter Bjornstad; Janet K Snell-Bergeon; Kimberly McFann; R Paul Wadwa; Marian Rewers; Christopher J Rivard; Diana Jalal; Michel B Chonchol; Richard J Johnson; David M Maahs
Journal:  J Diabetes Complications       Date:  2013-12-27       Impact factor: 2.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.